help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2005-0298
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/4/776    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J.
Right arrow Articles by Wong, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J.
Right arrow Articles by Wong, J.
Molecular Endocrinology 20 (4): 776-785
Copyright © 2006 by The Endocrine Society

A Role of the Amino-Terminal (N) and Carboxyl-Terminal (C) Interaction in Binding of Androgen Receptor to Chromatin

Jiwen Li, Junjiang Fu, Charalambos Toumazou, Ho-Geun Yoon and Jiemin Wong

Department of Molecular and Cellular Biology (J.L., J.F., C.T., J.W.), Baylor College of Medicine, Houston, Texas 77030; and Department of Biochemistry and Molecular Biology (H.Y.), Yonsei University College of Medicine, Soedaemoon-gu, Seoul 120-752, Korea

Address all correspondence and requests for reprints to: Jiemin Wong, Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030. E-mail: jwong{at}bcm.tmc.edu.

The N-terminal domain of AR is known to engage a hormone-dependent interaction with its C-terminal ligand-binding domain, and this N/C interaction is known to modulate AR transcriptional activity. Using Xenopus oocytes as a model system to study transcriptional regulation in chromatin, we found that two previously reported N/C interaction-defective AR mutants, one with deletion of 23FQNLF27(AR{Delta}F) and one with a Gly 21 to Glu mutation (ARG21E), were surprisingly inactive in activating transcription from various reporters assembled into chromatin. Further study using chromatin immunoprecipitation assay revealed that these mutants failed to bind both mouse mammary tumor virus-long terminal repeat and prostate-specific antigen enhancer assembled into chromatin. This defect is specific to chromatin because both mutants could bind to a consensus AR response element in vitro and activate transcription driven by mouse mammary tumor virus-long terminal repeat in transient transfection as effective as the wild-type AR. To further substantiate this novel finding, we established 293 cell lines that stably expressed either AR or AR{Delta}F mutant in an inducible manner. Using these cell lines, we confirmed by using chromatin immunoprecipitation assay that AR but not AR{Delta}F could bind to the endogenous prostate-specific antigen enhancer. Furthermore, we found that the AR{Delta}F mutant interacts poorly with Brg1, the ATPase subunit of the chromatin-remodeling factor SWI/SNF. Taken together, our study reveals a novel role of AR N/C interaction in control of AR chromatin binding and suggests a working model that the proper N/C interaction is required for AR to recruit SWI/SNF complex, which in turn remodels chromatin to allow AR to bind to AR response elements in chromatin.

NURSA Molecule Pages Link:

Nuclear Receptors:   AR
Coregulators:   p300  |  SRC-1  |  AIB1
Ligands:   R1881



This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
S. Bai and E. M. Wilson
Epidermal Growth Factor-Dependent Phosphorylation and Ubiquitinylation of MAGE-11 Regulates Its Interaction with the Androgen Receptor
Mol. Cell. Biol., March 15, 2008; 28(6): 1947 - 1963.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. M. Dehm and D. J. Tindall
Androgen Receptor Structural and Functional Elements: Role and Regulation in Prostate Cancer
Mol. Endocrinol., December 1, 2007; 21(12): 2855 - 2863.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. C. Hodgson, I. Astapova, A. N. Hollenberg, and S. P. Balk
Activity of Androgen Receptor Antagonist Bicalutamide in Prostate Cancer Cells Is Independent of NCoR and SMRT Corepressors
Cancer Res., September 1, 2007; 67(17): 8388 - 8395.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. B. Askew, R. T. Gampe Jr., T. B. Stanley, J. L. Faggart, and E. M. Wilson
Modulation of Androgen Receptor Activation Function 2 by Testosterone and Dihydrotestosterone
J. Biol. Chem., August 31, 2007; 282(35): 25801 - 25816.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Haelens, T. Tanner, S. Denayer, L. Callewaert, and F. Claessens
The Hinge Region Regulates DNA Binding, Nuclear Translocation, and Transactivation of the Androgen Receptor
Cancer Res., May 1, 2007; 67(9): 4514 - 4523.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Wu, H. Kawate, K. Ohnaka, H. Nawata, and R. Takayanagi
Nuclear Compartmentalization of N-CoR and Its Interactions with Steroid Receptors.
Mol. Cell. Biol., September 1, 2006; 26(17): 6633 - 6655.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society